DEL PAPA, BEATRICE
 Distribuzione geografica
Continente #
NA - Nord America 2.604
EU - Europa 1.662
AS - Asia 1.464
SA - Sud America 248
Continente sconosciuto - Info sul continente non disponibili 151
AF - Africa 47
OC - Oceania 1
Totale 6.177
Nazione #
US - Stati Uniti d'America 2.521
SG - Singapore 659
IT - Italia 406
IE - Irlanda 292
CN - Cina 274
BR - Brasile 186
DE - Germania 176
HK - Hong Kong 162
RU - Federazione Russa 154
VN - Vietnam 147
FI - Finlandia 110
SE - Svezia 105
UA - Ucraina 102
FR - Francia 87
GB - Regno Unito 79
KR - Corea 52
IN - India 46
CA - Canada 42
RO - Romania 40
BD - Bangladesh 25
TR - Turchia 24
BE - Belgio 22
MX - Messico 21
CZ - Repubblica Ceca 18
AR - Argentina 17
AT - Austria 14
PL - Polonia 14
CO - Colombia 13
EC - Ecuador 13
UZ - Uzbekistan 13
ES - Italia 9
JP - Giappone 9
MA - Marocco 9
ET - Etiopia 8
IQ - Iraq 8
LT - Lituania 7
PH - Filippine 7
PK - Pakistan 7
VE - Venezuela 7
ZA - Sudafrica 7
CH - Svizzera 6
CR - Costa Rica 6
CI - Costa d'Avorio 5
EG - Egitto 5
NL - Olanda 5
CL - Cile 4
KE - Kenya 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
DK - Danimarca 3
GR - Grecia 3
ID - Indonesia 3
JM - Giamaica 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
BG - Bulgaria 2
BO - Bolivia 2
HR - Croazia 2
KZ - Kazakistan 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MM - Myanmar 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
RE - Reunion 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
YT - Mayotte 1
Totale 6.027
Città #
Singapore 484
Chandler 294
Dublin 292
San Jose 253
Ashburn 230
San Mateo 193
Perugia 188
Hong Kong 162
Santa Clara 82
Boardman 80
Beijing 76
Council Bluffs 76
Ann Arbor 70
Munich 66
Jacksonville 55
New York 52
Seoul 52
Dong Ket 51
Los Angeles 50
Altamura 48
Princeton 48
Lauterbourg 47
Medford 46
Moscow 43
Helsinki 41
Bucharest 40
Andover 38
Turku 37
Wilmington 36
Lawrence 35
Foligno 33
Ho Chi Minh City 30
São Paulo 25
Dallas 23
Brussels 22
Dearborn 21
Hanoi 21
Piscataway 19
Redwood City 19
The Dalles 16
Houston 15
Toronto 14
Des Moines 13
London 13
Brno 12
Norwalk 12
Assisi 11
Brooklyn 11
Chicago 11
Izmir 11
Shanghai 10
Woodbridge 10
Frankfurt am Main 9
Orem 9
Rio de Janeiro 9
Tokyo 9
Vienna 9
Warsaw 9
Atlanta 8
Barnet 8
Falls Church 8
Saint Petersburg 8
San Paolo di Civitate 8
Addis Ababa 7
Belo Horizonte 7
Boston 7
Charlotte 7
Hefei 7
Mexico City 7
Montreal 7
Phoenix 7
Quito 7
Rome 7
San Francisco 7
Stockholm 7
Tashkent 7
Buffalo 6
Chennai 6
Da Nang 6
Denver 6
Falkenstein 6
Milan 6
Mumbai 6
San José 6
Abidjan 5
Ankara 5
Bogotá 5
Guangzhou 5
Bastia 4
Caracas 4
Casablanca 4
Changsha 4
Madrid 4
Nuremberg 4
Ottawa 4
Redmond 4
Amsterdam 3
Aurora 3
Baghdad 3
Biên Hòa 3
Totale 3.934
Nome #
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 191
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 187
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 187
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 167
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 165
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 151
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 146
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 144
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 141
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 140
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 139
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 136
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 132
Mesenchymal cells: a vehicle for gene therapy 131
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 129
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 129
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 129
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 127
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 125
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 125
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 123
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 122
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 122
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 118
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 118
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 118
T regulatory cell separation for clinical application. 117
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 113
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 113
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 112
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 109
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 108
Exploring the radiosensitizing potential of AZD8931: a pilot study on the human LoVo colorectal cancer cell line 105
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 103
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 101
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 100
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 99
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 98
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 97
Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. 94
New mechanism of lymphoma-induced bone marrow aplasia 94
Interleukin 7-engineered stromal cells: a new approach for hastening naive T cell recruitment 93
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production. 93
Catalase prevents DNA damage and cationic current activation by silver nanoparticles in U251 human glioblastoma cell line 92
Mesenchymal cells recruit and regulate T regulatory cells. 92
IL-7 engineered donor stromal cells in vitro: a new approach for hastening naive T cell recruitment. 84
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 83
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 82
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 78
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 72
NOTCH and Graft-Versus-Host Disease 71
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 70
null 37
Pre-test probability determines optimal ANA screening strategy: a risk-stratified comparison of indirect immunofluorescence and CTD screen assay 25
Totale 6.177
Categoria #
all - tutte 27.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022411 0 0 0 21 14 6 9 124 4 55 81 97
2022/2023910 48 169 8 82 75 83 0 45 346 1 35 18
2023/2024441 19 44 27 23 2 17 137 6 16 20 57 73
2024/2025826 41 82 19 43 93 29 44 55 148 43 133 96
2025/20261.883 123 122 85 198 288 201 321 92 198 193 44 18
2026/2027501 38 68 112 283 0 0 0 0 0 0 0 0
Totale 6.177